Table 3.

(Chemo-)radiation treatment details

	Radiation target volumes	Radiation dose	Boost / Elective fields	Chemotherapy
NSCLC trial	Primary lung tumour and involved regional lymph nodes	66 Gy in 24 fractions	N.A.	Cisplatin 6 mg/m2 1.5–2 h before radiation on every radiotherapy day#
Breast cancer trial	Whole breast and involved regional lymph node areas	46.69 Gy in 23 fractions	SIB of 14.49 Gy in 23 fractions to macroscopic tumour in breast; sequential boost of 10 Gy in 5 fractions to macroscopic lymph nodes (only if applicable)	N.A.
HNSCC trial	Primary tumour and regional metastatic lymph nodes; elective lymph node volumes based on site of primary tumour and stage	70 Gy in 35 fractions	Elective fields: 46 Gy in 23 fractions (sequential boost technique) or 54.25 Gy in 35 fractions (SIB technique)	N.A.

# in the CCRT arm only. Gy = Gray. N.A. = not applicable, SIB = simultaneous integrated boost